List of works - Cristina Sani

Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease

scientific article published on 22 November 2006

Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?

scientific article

Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients

scientific article published on 12 August 2010

Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies

scientific article published on 01 October 2004

Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood

scientific article published on 01 January 2002

Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection

scientific article published on 31 August 2017

Codon 72 polymorphism of p53 and HPV type 16 E6 variants as risk factors for patients with squamous epithelial lesion of the uterine cervix.

scientific article published on 4 November 2012

Comparing conventional and liquid-based smears from a consecutive series of 297 subjects referred to colposcopy assessment

scientific article published on 01 June 2004

Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting.

scientific article

Comparison of the conventional cervical smear and liquid-based cytology: results of a controlled, prospective study in the Abruzzo Region of Italy

scientific article published on 01 September 2008

Effectiveness of HPV vaccination in women reaching screening age in Italy

scientific article

Evaluation of bivalent human papillomavirus (HPV) vaccine safety and tolerability in a sample of 25 year old Tuscan women.

scientific article published on 9 April 2013

HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2.

scientific article published on 17 February 2018

HPV testing for primary cervical screening: Laboratory issues and evolving requirements for robust quality assurance.

scientific article

Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18-24: results at recruitment

scientific article

Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.

scientific article published on 21 November 2014

Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosis

scientific article published on 30 July 2009

Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker study

scientific article published on 07 April 2017

Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting

scientific article published on 01 November 2005

Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial.

scientific article published on 21 December 2012

Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology.

scientific article published on April 2006

Screening for colorectal cancer by faecal occult blood test: comparison of immunochemical tests

scientific article published on 01 January 2000

Technical evaluation of the new thin layer device CellSlide (Menarini Diagnostics).

scientific article published in December 2005

Triage with human papillomavirus testing of women with cytologic abnormalities prompting referral for colposcopy assessment

scientific article published on 01 February 2005

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.

scientific article published on 08 September 2008

List of works by Cristina Sani

Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease

Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?

Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients

Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies

Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood

Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection

Codon 72 polymorphism of p53 and HPV type 16 E6 variants as risk factors for patients with squamous epithelial lesion of the uterine cervix.

Comparing conventional and liquid-based smears from a consecutive series of 297 subjects referred to colposcopy assessment

Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting.

Comparison of the conventional cervical smear and liquid-based cytology: results of a controlled, prospective study in the Abruzzo Region of Italy

Effectiveness of HPV vaccination in women reaching screening age in Italy

Evaluation of bivalent human papillomavirus (HPV) vaccine safety and tolerability in a sample of 25 year old Tuscan women.

HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2.

HPV testing for primary cervical screening: Laboratory issues and evolving requirements for robust quality assurance.

Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18-24: results at recruitment

Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.

Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosis

Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker study

Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting

Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting

Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial.

Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology.

Screening for colorectal cancer by faecal occult blood test: comparison of immunochemical tests

Technical evaluation of the new thin layer device CellSlide (Menarini Diagnostics).

Triage with human papillomavirus testing of women with cytologic abnormalities prompting referral for colposcopy assessment

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.